Patents by Inventor Matthew Fosbrink

Matthew Fosbrink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32)
    Patent number: 8227194
    Abstract: The invention relates to antibodies that bind to a fragment of the Response Gene to Complement-32 (RGC-32), as well as methods of using these antibodies. Particular methods of using the antibodies of the present invention include, but are not limited to, methods of detecting RGC-32 in a sample, methods of assaying cell proliferation, as well as methods of detecting and/or monitoring the progression of abnormal conditions in a subject, where the disease states are associated with the presence or absence of RGC-32.
    Type: Grant
    Filed: April 10, 2006
    Date of Patent: July 24, 2012
    Assignee: University of Maryland, Baltimore
    Inventors: Horea Rus, Tudor Constantin Badea, Matthew Fosbrink
  • RESPONSE GENE TO COMPLEMENT 32 (RGC-32) IN DISEASE
    Publication number: 20110034344
    Abstract: The invention relates to antibodies that bind to a fragment of the Response Gene to Complement-32 (RGC-32), as well as methods of using these antibodies. Particular methods of using the antibodies of the present invention include, but are not limited to, methods of detecting RGC-32 in a sample, methods of assaying cell proliferation, as well as methods of detecting and/or monitoring the progression of abnormal conditions in a subject, where the disease states are associated with the presence or absence of RGC-32.
    Type: Application
    Filed: April 10, 2006
    Publication date: February 10, 2011
    Applicant: THE UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Horea Rus, Tudor Badea, Matthew Fosbrink